- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Anti-Aging
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Forum focus: Food allergy guidelines
New guidelines for the diagnosis and treatment of food allergy, released in December, will be examined by four panelists during a two-hour forum Feb. 5 at the annual meeting of the American Academy of Dermatology (AAD) in New Orleans, the academy announced.
Schaumburg, Ill. - New guidelines for the diagnosis and treatment of food allergy, released in December, will be examined by four panelists during a two-hour forum Feb. 5 at the annual meeting of the American Academy of Dermatology (AAD) in New Orleans, the academy announced.
“Food Allergy and Dermatology” will discuss the differences between food intolerance and food allergy, food allergy testing, and controversies in assessment and treatment.
The new guidelines were released in December by the National Institute of Allergy and Infectious Diseases (NIAID). The guidelines define food allergy not just as an immune reaction but as an “adverse health effect.” They also give treatment and management recommendations, such as noting that epinephrine, not oral antihistamines, is the drug of choice for treating acute symptoms.
The forum will be directed by Jon M. Hanifin, M.D., a professor in the department of dermatology at Oregon Health Sciences University, who helped develop the guidelines. Also speaking will be Matthew J. Fenton, Ph.D., chief of the NIAID’s Asthma, Allergy and Inflammation Branch; Lawrence Eichenfield, M.D., professor of pediatrics and medicine at the University of California, San Diego; and James Bergman, M.D., a pediatric allergist in Vancouver, British Columbia.
